首页> 美国卫生研究院文献>Pharmaceuticals >Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging
【2h】

Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging

机译:方便制备潜在Claudin-4 PET成像的18F标签肽探针

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since pancreatic cancer is often diagnosed in a late state of cancer development, diagnostic opportunities allowing early disease detection are highly sought after. As such, cancer expression of claudin proteins is markedly dysregulated, making it an attractive target for molecular imaging like positron emission tomography (PET). Claudins are a family of transmembrane proteins that have a pivotal role as members of the tight junctions. In particular, claudin-3 and claudin-4 are frequently overexpressed in pancreatic cancer. 18F-Labeled claudin selective peptides would provide access to a novel kind of imaging tools for pancreatic cancer. In this work we describe the synthesis of the first 18F-labeled probes potentially suitable for PET imaging of claudin-4 expression. These probes were prepared using oxime ligation of 5-[18F]fluoro-5-deoxyribose (5-[18F]FDR) to claudin selective peptides. As a proof-of-principle, one of them, 5-[18F]FDR-Clone 27, was isolated in >98% radiochemical purity and in 15% radiochemical yield (EOB) within 98 min, and with a molar activity of 4.0 GBq/μmol (for 30 MBq of tracer). Moreover, we present first biological data for the prepared 5-FDR-conjugates. These tracers could pave the way for an early diagnosis of pancreatic tumor, and thus improve the outcome of anticancer therapy.
机译:由于通常在癌症发展的晚期阶段诊断出胰腺癌,因此强烈寻求能够早期发现疾病的诊断机会。因此,claudin蛋白的癌症表达明显失调,使其成为分子成像(如正电子发射断层扫描(PET))的有吸引力的靶标。 claudins是跨膜蛋白家族,作为紧密连接的成员具有关键作用。特别地,claudin-3和claudin-4在胰腺癌中经常过表达。 18 F标签的claudin选择性肽将提供一种新型的胰腺癌成像工具。在这项工作中,我们描述了第一个 18 F标记的探针的合成,该探针可能适用于claudin-4表达的PET成像。这些探针是通过将5-[ 18 F]氟-5-脱氧核糖(5-[ 18 F] FDR)肟连接到claudin选择性肽上而制备的。作为原理的证明,在98分钟内分离出了其中一种,即> [98%放射化学纯度和15%的放射化学产率(EOB)],即5-[ 18 F] FDR-Clone 27。 ,且摩尔活性为4.0 GBq /μmol(对于30 MBq示踪剂)。此外,我们介绍了制备的5-FDR结合物的第一批生物学数据。这些示踪剂可以为胰腺肿瘤的早期诊断铺平道路,从而提高抗癌治疗的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号